The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia

Haematologica

Volumn 90, Issue 12, 2005, Pages 1699-1701

  Galmarini, Carlos María ^a   Cros, Emeline ^a   Thomas, Xavier ^b   Jordheim, Lars ^a   Dumontet, Charles ^a  

^a CENTRE LÉON BÉRARD   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

5 nucleotidase; Cytarabine; Drug resistance; Leukemia

Indexed keywords

5' NUCLEOTIDASE; CYTARABINE; CYTIDINE PHOSPHATE; DEOXYCYTIDINE KINASE; MESSENGER RNA; PHOSPHOTRANSFERASE; URIDINE PHOSPHATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ADULTHOOD; AGED; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS;

EID: 29144492798     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol 2002;3:415-24.
2. Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 2001;15:875-90.
3. Galmarini CM, Graham K, Thomas X, Calvo F, Rousselot P, El Jafaari A, et al. Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood 2001;98:1922-6.
4. Twentyman PR, Fox NE, Rees JK. Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br J Haematol 1989;71:19-24.
5. Galmarini CM, Thomas X, Calvo F, Rousselot P, Jafaari AE, Gros E, et al. Potential mechanisms of resistance to cytarabine in AML patients. Leuk Res 2002;26:621-9.
6. Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A, et al. In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol 2002;117:860-8.
7. Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, et al. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br J Haematol 2003;122:53-60.
8. Mazzon C, Rampazzo C, Scaini MC, Gallinaro L, Karlsson A, Meier C, et al. Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. Biochem Pharmacol 2003;66:471-9.
9. Chiba P, Tihan T, Szekeres T, Salamon J, Kraupp M, Eher R, et al. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloia leukemia after repeated treatment with ara-C in vivo. Leukemia 1990;4:761-5.
10. Amici A, Magni G. Human erythrocyte pyrimidine 5′-nucleotidase, PN-I. Arch Biochem Biophys 2002;397:184-90.